Ferdinand Kiemeneij, M.D., explains the history of the transradial access during an interview with DAIC at TCT 2017.
Feature | Radial Access | Dave Fornell

Interventional cardiology has witnessed a rapid and constant evolution in both techniques and device technology since ...

Home February 22, 2018
Home
News | ECMO Systems

When someone goes into cardiac arrest and first responders cannot shock their heart back into rhythm, there is virtually no chance of survival. However, a new protocol being tested at The Ohio State University Wexner Medical Center is already saving lives – increasing survival rates from zero to about 40 percent.

Home February 22, 2018
Home
Technology | Left Atrial Appendage (LAA) Occluders

February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V Left Atrial Appendage (LAA) ...

Home February 22, 2018
Home
News | Vascular Closure Devices

Vascular closure device provider Cardiva Medical announced that the company has closed on $11 million in additional financing – bringing total equity and debt financing in the current round to $41 million. The additional financing exceeds previous commitments for this round and includes returning equity and debt investors – including PTV Healthcare Capital, Canepa Healthcare, and affiliates of Luther King Capital Management.

Home February 21, 2018
Home
News | Cardiovascular Business

The U.S. Food and Drug Administration (FDA) issued the final rule on “Human Subject Protection; Acceptance of Data from Clinical Investigations for Medical Devices.” The rule updates the FDA’s standards for accepting clinical data from clinical investigations conducted both inside and outside the United States to help ensure the protection of human participants, and to help ensure the quality and integrity of data obtained from these clinical investigations.

Home February 21, 2018
Home
Technology | Peripheral Artery Disease (PAD)

Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its CorPath GRX System in peripheral vascular interventions. The CorPath System is the first and only FDA-cleared medical device, according to the company, to bring robotic precision to both percutaneous coronary intervention (PCI) and peripheral vascular intervention (PVI) procedures.

Home February 20, 2018
Home
News | Artificial Intelligence

Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body solution utilizing artificial intelligence (AI) to help analyze computed tomography (CT) scans, highlighting medical findings for radiologists. The workflow-integrated solution offers support for radiologists covering areas such as the head, c-spine, chest and abdomen.

Home February 20, 2018
Home
An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate vessel segments that are occluded and not visible on angiography alone.
Feature | Chronic Total Occlusion (CTO) | Dave Fornell

One of the recent hot topics in interventional cardiology has been how operators can use new tools and techniques to ...

Home February 20, 2018
Home
News | Cardiovascular Clinical Studies

February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commencement ...

Home February 20, 2018
Home
News | Information Technology

February 20, 2018 – LUMEDX Corporation, a top cardiovascular data intelligence company, will show off the latest in ...

Home February 20, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

A late-breaking analysis of the landmark COMPASS study was presented at the 2018 International Stroke Conference (ISC), showing that people with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) taking Xarelto (rivaroxaban) had fewer ischemic strokes compared to those taking aspirin alone. This analysis, which specifically examined patients from COMPASS who experienced a stroke, also found high-risk patients taking Xarelto plus aspirin had the largest reductions in stroke.

Home February 19, 2018
Home
News | Stents Drug Eluting

February 19, 2018 — The Detroit Medical Center’s (DMC) interventional cardiology team at Heart Hospital recently became ...

Home February 19, 2018
Home
News | Embolic Protection Devices

Claret Medical announced that since U.S. Food and Drug Administration (FDA) clearance in June 2017, its Sentinel Cerebral Protection System has been adopted by 50 U.S. centers as part of its controlled rollout. The company said that some institutions have adopted the device as an emerging standard of care in the U.S. to protect patients from the risk of stroke by capturing and removing debris associated with transcatheter aortic valve replacement (TAVR) before it travels to the brain. The novel system has been shown to significantly reduce the risk of stroke in the first three days after TAVR by more than 60 percent, according to Claret Medical.

Home February 19, 2018
Home
The Lumedx cardiovascular information system (CVIS or CPACS) offers integration of data from across the cardiovascular service line into one location.
Feature | Cardiovascular Information Systems (CVIS) | Dave Fornell

For any cardiology department planning to upgrade its cardiovascular picture archiving and communication system (cardiac ...

Home February 19, 2018
Home
News | Hypertension

February 16, 2018 — California’s Petaluma Health Center (PHC) was recently awarded a 2017 Healthcare Information and ...

Home February 16, 2018
Home
Subscribe Now